큐리옥스바이오시스템즈

445680KOSDAQ

50.0 / 100

Reference Date: 2026-09-08

Financial Score12.0 / 40

News Sentiment19.0 / 25

Momentum9.0 / 20

Disclosure10.0 / 15

AI Analysis: the debt ratio is very low with excellent financial health but ROE is below the industry average. Surged 23.1% over the past month, and news sentiment is positive.

Company InformationBased on 2025 Annual Report

Business Overview

Curiox Biosystems sells automated equipment and consumables for cell analysis processes, leveraging its decade-long developed Curiox C-FREE™ technology to automate preprocessing steps, significantly improving data accuracy and reproducibility. This technology, based on microfluidics and surface science, is used by pharmaceutical companies and research institutions in the US, Europe, and China. The company has subsidiaries in the US, China, and Singapore to expand its global market presence.

Number of Employees

22people

Average Salary

70.4M KRW

Score Calculation Basis

Detailed Financial Score

PER

—Industry Average 15.004.0Point

PBR

16.52Industry Average 1.200.0Point

13.8x industry avg (risky)

ROE

-53.58Industry Average 8.000.0Point

Well below industry avg

Debt Ratio

3.49Industry Average 100.008.0Point

Half of industry avg (excellent)

Trend 2023~20250.0 / 10 points

Revenue Growth Rate

0.0 / 3

Avg ▼10.1% (2-year basis)

Operating Profit Growth Rate

0.0 / 3

Avg ▼9.4% (2-year basis)

ROE Trend

0.0 / 4

Avg ROE -30.1% (declining, 3yr)

Detailed News Sentiment

6 totalPositive 5Neutral 1Negative 0Average Sentiment Score 75.8

Positive
김남용 큐리옥스 대표 "글로벌 기업과 수주 계약, 선입금 계약 또 나올...
큐리옥스바이오시스템즈는 글로벌 제약사로부터 세포·유전자치료제 장비 수주를 확보하며 긍정적인 성장 신호를 받았습니다.
Positive
오늘의 메모[8월 25일]
큐리옥스바이오시스템즈의 주식매수선택권 행사로 인한 긍정적인 시장 반응 반영.
Positive
큐리옥스 '멀티유닛' 수주에 上…올릭스, CPS 오버행 부담에 발목[바...
큐리옥스바이오시스템즈는 글로벌 제약사의 멀티유닛 수주로 인해 상한가를 기록하며 긍정적인 주가 반응을 보였다.

Detailed Momentum

52-week position1.0Point

Near 52w low (15%, downtrend)

Current 50,700Won52-week high 139,60052-week low 34,300

1-month return6.0Point

1m +23.06% (strong rise)

Volume trend2.0Point

Volume decreasing

Detailed Disclosure

5 totalPositive 0Neutral 5Negative 0

Neutral반기보고서 (2026.06)2026-08-14
Neutral[기재정정]주식매수선택권부여에관한신고2026-08-12
Neutral주식매수선택권부여에관한신고2026-08-11
Neutral임원ㆍ주요주주특정증권등소유상황보고서2026-08-10
Neutral주식등의대량보유상황보고서(일반)2026-08-10